Thursday, September 19, 2013

The Strategy That Will Fix Health Care - HBR

Full Article: http://hbr.org/2013/10/the-strategy-that-will-fix-health-care/ar/1

by Michael E. Porter and Thomas H. Lee

Visit our Insight Center, Leading Health Care Innovation, for more on how leaders and managers in health care can improve patient outcomes and lower costs.
In health care, the days of business as usual are over. Around the world, every health care system is struggling with rising costs and uneven quality despite the hard work of well-intentioned, well-trained clinicians. Health care leaders and policy makers have tried countless incremental fixes—attacking fraud, reducing errors, enforcing practice guidelines, making patients better “consumers,” implementing electronic medical records—but none have had much impact.
It’s time for a fundamentally new strategy.
At its core is maximizing value for patients: that is, achieving the best outcomes at the lowest cost. We must move away from a supply-driven health care system organized around what physicians do and toward a patient-centered system organized around what patients need. We must shift the focus from the volume and profitability of services provided—physician visits, hospitalizations, procedures, and tests—to the patient outcomes achieved. And we must replace today’s fragmented system, in which every local provider offers a full range of services, with a system in which services for particular medical conditions are concentrated in health-delivery organizations and in the right locations to deliver high-value care.
Making this transformation is not a single step but an overarching strategy. We call it the “value agenda.” It will require restructuring how health care delivery is organized, measured, and reimbursed. In 2006, Michael Porter and Elizabeth Teisberg introduced the value agenda in their book Redefining Health Care. Since then, through our research and the work of thousands of health care leaders and academic researchers around the world, the tools to implement the agenda have been developed, and their deployment by providers and other organizations is rapidly spreading.
The transformation to value-based health care is well under way. Some organizations are still at the stage of pilots and initiatives in individual practice areas. Other organizations, such as the Cleveland Clinic and Germany’s Schön Klinik, have undertaken large-scale changes involving multiple components of the value agenda. The result has been striking improvements in outcomes and efficiency, and growth in market share.
There is no longer any doubt about how to increase the value of care. The question is, which organizations will lead the way and how quickly can others follow? The challenge of becoming a value-based organization should not be underestimated, given the entrenched interests and practices of many decades. This transformation must come from within. Only physicians and provider organizations can put in place the set of interdependent steps needed to improve value, because ultimately value is determined by how medicine is practiced. Yet every other stakeholder in the health care system has a role to play. Patients, health plans, employers, and suppliers can hasten the transformation—and all will benefit greatly from doing so.
Defining the Goal
The first step in solving any problem is to define the proper goal. Efforts to reform health care have been hobbled by lack of clarity about the goal, or even by the pursuit of the wrong goal. Narrow goals such as improving access to care, containing costs, and boosting profits have been a distraction. Access to poor care is not the objective, nor is reducing cost at the expense of quality. Increasing profits is today misaligned with the interests of patients, because profits depend on increasing the volume of services, not delivering good results.
In health care, the overarching goal for providers, as well as for every other stakeholder, must be improving value for patients, where value is defined as the health outcomes achieved that matter to patients relative to the cost of achieving those outcomes. Improving value requires either improving one or more outcomes without raising costs or lowering costs without compromising outcomes, or both. Failure to improve value means, well, failure.

Why Health Care Is Stuck — And How to Fix It - HBR

http://blogs.hbr.org/2013/09/why-health-care-is-stuck-and-how-to-fix-it/

80-porter-lee

Michael E. Porter is the Bishop Lawrence University Professor at Harvard University. He is based at Harvard Business School. Thomas H. Lee, MD, is the chief medical officer at Press Ganey and the former network president of Partners HealthCare.







The pressures for fundamental change in health care have been building for decades, but meaningful change has been limited while the urgency of change only grows. The moment of discontinuity has arrived. Already unsustainable costs, an aging population, advances in medicine, and a growing proportion of patients in low reimbursement government programs have made the status quo unsustainable. Change is inevitable.
There is only one real solution, which is to dramatically increase the value of health care. Value is the outcomes achieved for patients relative to the money spent. Without major improvements in value, services will need to be restricted, the incomes of health care professionals will fall, and patients will be asked to pay even more.
In our October Harvard Business Review article “The Strategy That Will Fix Health Care” we describe the strategic agenda that is necessary to create a high value health care delivery system.We believe that there is no longer any doubt about how to increase the value of care. The question is whether providers can make the necessary changes.
Why has it been so hard for health care organizations to improve outcomes and efficiency, despite their best intentions? With so many good, smart people working so hard? With patients’ needs so obvious and so compelling? And with such deep societal concerns about health care spending? The answer is complex, but the result is clear: progress in health care has been all but paralyzed by self-reinforcing barriers to change.
We are confident that providers can overcome these barriers by starting with a shared understanding of why they are stuck.  We think the most important barriers include the following:
Providers are organized and reimbursed around what they do, rather than what patients need.
Most health care delivery organizations are organized around physicians and specialties. Within a hospital, physicians are members of the departments and divisions and specialize in what they were trained to do. They treat a broad range of conditions relevant to their field—for example, a neurologist will see patients with headaches, provide stroke care, and treat multiple sclerosis and other conditions with a neurological component. Physicians are physically located in their specialty units, and patients are expected to find their way to them. In this structure, physicians generally work hard to help patients during each encounter – and their assumption is that if they do so, they are doing their job.  In this context, their efforts to improve care have focused largely on raising the volume of the discrete services they provide, with “efficiency” gauged in terms of “throughput.”
This approach may have made more sense in the past, when there was so much less that medicine could do, and it was possible for specialists to know all there was to know in their field. Today, however, medical progress has made many previously untreatable diseases treatable, and some even curable. Many more types of clinicians must work together to deliver state-of-the-art care. A patient with diabetes, for example, might need care from physicians trained in endocrinology, nephrology, cardiology, vascular surgery, ophthalmology, podiatry, and primary care.
Yet the current siloed organization of care makes multidisciplinary, integrated care extremely difficult, even if clinicians are part of the same institution and utilize the same electronic medical records. At one well-known teaching hospital, a survey showed that 15% of staff physicians did not realize that they were all members of the same physician organization. This is an indication of how strong their main identification is with their specialty divisions.
In this legacy structure, effective teamwork is possible but it doesn’t happen naturally. Duplication and delay are built into the system. Patients are forced to coordinate their own care and make sure their various physicians are communicating.
Care fragmentation is reinforced by the fee-for-service model in which each doctor, specialist or otherwise, is paid separately, while the hospital receives its own payment.  Physicians believe that they are compensated for what they do as individuals; basic teamwork functions that are critical to meeting the needs of patients, like meetings to review performance or even using the electronic medical record, are sometimes labeled “unfunded mandates.” Some high-value services are not reimbursed at all, such as follow-up telephone contact after hospitalizations or “virtual” or informal consultations that avert the need for an office visit. The result is that crucial work required for high value care does not get done.
Some new payment models provide reimbursement for care coordinators, but those coordinators are typically superimposed over the current fragmented care process, leaving the basic organizational structure intact. Although an overlay is less disruptive than restructuring the organization of care, it adds cost and essentially treats the symptom of faulty organization rather than the cause. And those added costs have led many to mistakenly conclude that excellent care is inherently more costly, which has hindered efforts to guide patients to the highest-value providers.
Free-agent physicians operate independently, rather than as part of an integrated team.
Not only is care siloed by specialty, but much specialty care in the U.S. is delivered by independent physicians in private practice. A study of Medicare patients, for example, showed that patients saw a median of seven different physicians in four different practices each year, with little or no integration among them.
In many ways, independent doctors have dominated medicine’s culture. “Free agent” physicians view themselves as equity-owners of autonomous businesses, and few have placed a high priority on integrating care with other clinicians as a means to improve value for patients. Instead, there are tensions among different specialists over what they are paid. And, there are inevitable conflicts with hospitals over compensation, staffing, desired facilities, and who should bear risk, not to mention threats to move business to other hospitals. All of this makes multidisciplinary, integrated care challenging – or impossible.
To address these issues, there are a growing number of joint venture models in which hospitals and independent physicians become partners, but the jury is still out on their impact and durability. Joint ventures can help boost integration and shift care to higher value models, but complexity remains about decision rights, responsibilities, and dividing revenues. Such joint ventures often fall short of true partnership, and prove fruitless.
The proportion of physicians that are employed is rising, an important enabler of high value care. When all the physicians involved in care are employed by a larger organization, teamwork can become part of the job description. However, the trust that is crucial to well-functioning teams takes time and work to develop especially when physicians have only recently become employed.
Patient volume is fragmented, making every patient a special case.
Health care systems in virtually every country, including the U.S., disperse rather than aggregate patients with similar needs. A century ago, hospitals sprang up in almost every small town or city, and served any patient walking in the door. This made sense when there was not much that medicine could do for many patients beyond relieving their symptoms. Because hospitalizations could easily last a month or more, close proximity was essential to allow visits by family members. The result was that most providers treated a relatively small number of most types of cases.
Today, however, medicine is far more advanced and specialized and lengths of stay are much shorter. Treating a high volume of patients with a particular medical condition is critical to value, to build experience in highly sophisticated and technical diagnostics and procedures, work more effectively in multidisciplinary teams, and better measure how patients are doing. In the existing fragmented system, providers have limited experience in each type of case, leading to less efficiency, more dropped balls, and worse patient outcomes. Fragmentation also means that most providers are unable to integrate support personnel with specialized skills in a disease area directly into the team —such as nutritionists or behavioral health specialists. There is overwhelming evidence that having a high volume of patients with a particular condition is important to value, and, conversely, that care by local providers with small populations can lead to poor outcomes.
Despite the clear benefit of focusing on the areas with adequate patient volume, providers tend to cling to every service line and duplicate services across health systems. Boards of directors are loath to close services in any facility, in part because politicians mistakenly equate local service with better care. Antitrust regulators are also remain wary of consolidation, mistakenly seeing the relevant market as highly localized and believing that the more providers of a given service in the region the better.
Massive cross-subsidies in reimbursement for individual services have distorted care and stalled care integration.
Under the prevailing fee-for-service payment system, there is a loose relationship at best between the fees paid and the actual costs of performing that service. Flawed reimbursement methodologies have made some services lucrative (for example, radiology and chemotherapy), while others are reimbursed below actual costs (mental health and palliative care, for instance). Organizations use high-margin services to cross-subsidize the money-losing areas, with severe, perverse consequences. Virtually every provider organization is motivated to invest in profitable services like bariatric and vascular surgery in a desperate grab for enough lucrative business to stay alive. The result is excess capacity and overprovision of these services, yet insufficient volume for most providers to deliver excellent or efficient care.
Cross-subsidization across services, even those needed in caring for the same condition such as less reimbursed cardiology drug therapy and highly reimbursed interventional procedures, works against making the highest value care choices while creating tensions among providers, undermining team-based, integrated care. Providers involved in patients’ care fight over responsibility and compensation rather work together. High value but poorly reimbursed services, such as palliative care, are underprovided.
No participant in the system has good information about patient outcomes and the cost of care.
Flying blind is dangerous. When there are no data on how you are doing, and whether new interventions or practices actually improve outcomes or lower costs, initiatives to improve performance can end up doing more harm than good.
The shocking truth in health care is that there are few data on the actual outcomes that matter to patients with specific conditions. Instead of recognizing that quality is determined by outcomes, providers tend to define quality on the basis of compliance with guidelines (for example, reliability in ordering certain tests or “door-to-balloon” time for patients with myocardial infarction) and patient status as measured by a limited number of clinical indicators (such as LDL cholesterol levels and hemoglobin A1c) which are incomplete predictors of outcomes but not actual outcomes themselves.
There is also a near complete absence of data on the true costs of care for a patient with a particular condition over the full care cycle, crippling efforts to improve value. The lack of cost information starts with widespread confusion about the difference between costs and charges. Most clinicians also have no way of knowing what things actually cost or how much time care processes take. Without the ability to understand the costs of the care for specific conditions, or how costs compare to outcomes, efforts at cost reduction revert to power struggles and arbitrary cuts. Efforts to improve performance become mired in turf wars, personal opinions, and clashes of ego. Resources tend to flow to services that seem to be the most profitable or whose advocates are most skilled in internal politics.
Information technology has often made care integration and value improvement harder, rather than enabling it.
Most clinical information systems have been designed around specialties, procedures, or care sites, and focused on scheduling and fee-for-service billing. Few systems were designed to keep track of individual patients over a full care cycle, and provide all the caregivers involved with comprehensive patient information. Few if any clinicians involved in the care of a patient have complete information. Information systems can also make it almost impossible to collect information on outcomes that matter. Highly relevant data (for example, incontinence or falls) are not captured in EMRs at all, and much outcome information is buried in “free text” fields within clinician notes, which makes it hard to extract or act upon.
The information systems used by health insurance plans have been no better, and maybe worse. They are designed to adjudicate and pay bills for individual services not measure the overall care and value for patients. Most insurers cannot even capture whether a patient is dead or alive. Good luck trying to piece together the overall charges for one episode of care if it spans the end of the calendar year.  Faulty information systems make it all too easy to give up and continue with business as usual. For example, insurers throw up their hands about bundled payments because legacy systems are coded for fee-for-service payments.
BREAKING DOWN THE BARRIERS
As the figure below shows, the barriers to change in the legacy system are interdependent and mutually reinforcing.
Fee-for-service payments for specialties as well as private practice physicians reinforce the siloed organization of care. Fragmented IT solutions work against multidisciplinary care models, rather than enabling them. Misunderstandings about profitability because of inaccurate costing leads to overly broad service lines, a problem exacerbated by the fact that providers attempt to serve all the needs in their service area. Low patient volumes in many conditions, due to serving only the immediate geographic area and duplicating  services across locations, reinforce the siloed structure of care delivery because providers cannot afford to have dedicated teams. And so on.
The Legacy System Chart
Because these barriers to change reinforce each other, incremental fixes do not work.  As a result, progress in truly restructuring health care delivery has been stymied. The legacy structure almost guarantees low or uneven value for patients, yet it is extremely resistant to change.
These barriers to change make it clear that to move from the legacy system to a value-based system needs to be a true strategic transformation, not just a series of isolated steps. In our article, we describe the six components of this transformation, from organizing into integrated practice units, and measuring outcomes and costs, to expanding excellent service geographically and building a new kind of IT platform, as shown in the figure below.
The Value Based System Chart
This transformation will not happen overnight and each component will take time to roll out. But a true solution to our health care problem is within our grasp.
Follow the Leading Health Care Innovation insight center on Twitter @HBRhealth. E-mail us athealtheditors@hbr.org, and sign up to receive updates here.
Leading Health Care Innovation
From the Editors of Harvard Business Review and The New England Journal of Medicine
More on: Health, Strategy
80-porter-lee

Michael E. Porter is the Bishop Lawrence University Professor at Harvard University. He is based at Harvard Business School. Thomas H. Lee, MD, is the chief medical officer at Press Ganey and the former network president of Partners HealthCare.

Tuesday, September 17, 2013

Blue Button Access to Health Records Will Save Lives

        
val lawless/Shutterstock.com

http://www.nextgov.com/health/2013/09/blue-button-access-health-records-will-save-lives-top-techie-says/70398/
Patient access to electronic health information through the Blue Button project pioneered by the Veterans Affairs Department in 2010 will literally save lives, federal Chief Technology Officer Todd Park said Monday.
Speaking at the Health and Human Services Department Consumer Health IT Summit, Park described Blue Button as a “movement” -- embraced by individual doctors, large health care providers and insurers -- that allows patients to access their data and share it with their clinicians and family members.
Blue Button has already been adopted by 500 insurers and health care organizations that collectively cover 100 million people, nearly one-third of the U.S. population, according to Lygeia Ricciardi, director of the consumer electronic-health office at HHS.
Robert Tagalicod, director of an electronic health office at the Centers for Medicare and Medicaid Services said one million CMS patients already use Blue Button to access their information.
As of next Monday new regulations will require clinicians to offer patients records in an electronic format for a nominal fee, according to Leon Rodriguez, director of the HHS  Office for Civil Rights. He emphasized that under the Health Insurance Portability and Accountability Act, or HIPAA, patients are entitled to their records, whether electronic or paper.
When VA started the Blue Button project, it initially provided data in plain ASCII text but now also provides continuity-of-care data to veterans in machine readable and “actionable” format, Marina Martin, VA CTO told the conference. Martin said that the VA also has plans to make X-ray and other clinical imaging data available to veterans through its Blue Button portal.
Pharmacy giant Walgreens -- with 8,000 stores located within five miles of 75 percent of the U.S. population -- has embraced Blue Button with both desktop computer and mobile apps that provide customers with, among other things, a downloadable PDF file of all their prescriptions, according to Adam Pellegrini, vice president of digital health at the chain.
The most popular mobile developed by Walgreens allows consumers to scan a prescription barcode for automatic refills, Pellegrini said.
Park said investors have “bit big on Blue Button,” which Farzad Mostashari, national coordinator for Health IT, said shows how a good idea developed and incubated by the government has filtered into the private sector.
Credit reporting firm Experian plans to develop secure storage for patient health information, according to Mark Kapczynski, vice president of corporate development and strategy for the Consumer Direct division of the company.
Dr. Bijan Salehizadeh, managing director of NaviMed Capital, a private equity firm with Silicon Valley roots, told the conference that he sees “record levels of investment” in health IT due to the groundwork done by the federal government, along with hardware and software ubiquity

Sunday, September 15, 2013

FROM GUTTENBERG TO ZUCKERBERG: SOCIAL NETWORKING IS CHANGING THE CHURCH



The Center for Pastoral Counseling (Springfield, Delaware) is offering a one-day seminar entitled "From Guttenberg to Zuckerberg: How Social Media is Changing the Church" on Saturday, October 26 at the Covenant United Methodist Church in Springfield, PA.  Designed specifically to help pastors and interested laypersons enhance their use of social media. . It will begin at 8:30 a.m. The featured speaker will be the Rev. Keith Anderson, pastor of the Upper Dublin Lutheran Church in Ambler and co-author of Click2Save: the Digital Ministry Bible.  Click on the image for all details and registration information.

The Blue Button Movement: Kicking off National Health IT Week with Consumer Engagement - HHS

Read more: http://www.healthit.gov/buzz-blog/electronic-health-and-medical-records/blue-button-movement-kicking-national-health-week-consumer-engagement/

Next week the Department of Health & Human Services – and ONC – is helping to kick off National Health IT Week (#NHIT) with the third annual Consumer Health IT Summit: Accelerating the Blue Button Movement. Registration is full, but you can sign up for the wait list or participate virtuallyonline. This year’s National Health IT Week Consumer Summit celebrates consumer and patient engagement in health and healthcare via health information technology. This year we’ve decided to include “Blue Button” in its title. We get a lot of questions about what “Blue Button” is and what it stands for. It’s evolved rapidly in the last few years, so I’d like to help set the record straight.
Blue Button is a Tool for Consumers
On the simplest level, Blue Button is a literal “button” appearing on many websites that lets consumers get their health information online. The Veterans Administration (VA) was first to display the Blue Button symbol on its patient portal in 2010, and veterans quickly embraced it. Then, as now, a veteran could click on the Blue Button icon to securely download their health information electronically. The VA’s definition of Blue Button specified a particular technical format (ASCII text or PDF), which enabled patients to read, print, or store their health records in a straightforward but bare bones way.
Soon, Blue Button spread beyond its VA roots to other government agencies and the private sector. It became so popular that last year leadership of the Blue Button initiative was transferred to ONC, which, as the “national coordinator” and champion of consumer engagement in health is well positioned to support its nationwide growth. The VA and other agencies continue to use Blue Button in practice and to help ONC improve it.
To encourage Blue Button’s growth and keep up with a rapidly changing technical environment, ONC has both loosened technical requirements for use of the Blue Button logo and developed voluntary guidelines for implementing Blue Button in a more structured way that is consistent with Meaningful Use requirements. The Blue Button Plus guidelines,) which were developed collaboratively with 68 volunteer organizations, enable organizations such as doctors’ offices, hospitals, and payers to standardize the structure and transport of health information and electronic health records to support the use of more sophisticated tools that allow consumers to better share their Blue Buttoned-information with others they trust and plug them into in apps and tools. The Blue Button Plus technical guidelines also make it easier for consumers to get automatic updates to their health records (e.g. “set it and forget it”).  There are ongoing opportunities to contribute to the development of additional standards guidelines associated with Blue Button for those who are interested.
Blue Button is a Social Movement  
When a new concept emerges, creating a word and/or image to represent it can help to solidify it. Getting a copy of your own health records (especially electronically) is a relatively novel behavior for most people, and many are not aware that they have the legal right, under HIPAA, to do so.
Other “concept” symbols (as opposed to brands for a specific product) include the EnergyStar and Organic Foods symbols, which were both created by the federal government and are now widely used by the private sector. In addition, the recycling symbol, like Blue Button, is both an action-oriented signpost (“put your plastic bottles in this bin”) and something more (it can convey the aspiration: “protect the environment!”).
Similarly, the Blue Button symbol is becoming a rallying cry for change, a shorthand way of referring to the growing reality and future potential of consumer and patient engagement supported by better health information and tools. Across the country the Blue Button is popping up on patient portals and health education websites, on smart phone apps and in doctors’ offices. Trade press, bloggers and Twitter are abuzz about it. Bill Clinton even talked about it at the HIMSS conference last spring, and large, influential patient advocacy organizations such as the American Cancer Society are adopting it, urging their membersto look for the Blue Button to access and use their own health information
Blue Button is the Future
With more than half of Americans using smart phones today, and an abundance of popular health apps and tools such as digital pedometers, glucose monitors, and sleep sensors, consumers are becoming an undeniable part of the equation for better health and healthcare through health information technology.
Today, via ONC’s Blue Button Pledge Program more than 450 organizations are committed to making personal health information available to Americans nationwide via their providers, health plans, labs, and pharmacies; building tools to make health information actionable for patients; and/or spreading the word about why all this matters. That’s a great start, but we are only at the beginning of an exciting journey. Won’t you join us?
If you are a consumer, patient or caregiver (and who isn’t?):
  • See if your healthcare provider or plan offers Blue Button, and encourage your loved ones to do the same
If you represent an organization in the healthcare field:
  • Take the Blue Button Pledge
  • Use the Blue Button logo and phrase
  •  Help spread the word. Blog, tweet #BlueButton, and use other social media to talk to consumers about the importance of engaging in your health. Use our animated video and stay tuned for some announcements about new materials to be released next week
  • If you provide consumer access to health information  or an app that lets consumers use their health records, get listed on our “Blue Button Hub” website — more details to come next week


Accessing Your Health Information With the Blue Button - HHS

Read more: http://www.healthit.gov/bluebutton


Accessing Your Health Information With the Blue Button

The Blue Button signifies that you—as an individual consumer or patient—can get easy, secure electronic access to your own health information in a format you can use. As Americans, we each have the legal right to see and get a copy of our own health information held by doctors, hospitals and others that provide health care services for us. But many of us don't, either because we don't know we can, or because we're not sure what to do with it. Until recently, most medical information was stored in paper files, so it wasn't very easy to access or use anyhow. But all that is changing as America's health care system rapidly goes digital.
Through the Blue Button, you may have access to your claims or personal health information that is maintained by your doctors, hospitals, health plans, and others.

Learn more:

  • About Blue Button

    What is the Blue Button? What are the benefits? How can I get access to my electronic health data and what can I do with it?
  • Frequently Asked Questions

    Frequently asked questions and answers about Blue Button for various stakeholder groups—the general public, data holders (health care providers & health plans), technology developers, et al.
  • Logo and Usage

    Defines guidelines for use of the Blue Button logo.
  • For Developers – Blue Button+ Implementation Guide External Links Disclaimer

    Guidance for organizations and third party app developers to implement Blue Button+.
  • Get Involved

    This page contains information about how organizations can pledge to support the Blue Button initiative or get involved in efforts to enhance the technical capability of Blue Button.
  • Watch this Video to Find out Why

    Find out why having access to your health information electronically can help you share your information with your doctors and be prepared in case of an emergency.
  • Contact Us

    For information about the Blue Button program, email bluebutton@hhs.gov.

Thursday, September 5, 2013

The Costly Paradox of Health-Care Technology - MIT Technology Review

WHY IT MATTERS
Health-care costs would drop if we stuck to technologies with proven benefits.

PART OF OUR BUSINESS REPORT:

A Cure for Health-Care Costs

Health-care spending is out of control. Can technology save us money?
In every industry but one, technology makes things better and cheaper. Why is it that innovation increases the cost of health care?
Read more: http://www.technologyreview.com/news/518876/the-costly-paradox-of-health-care-technology/?utm_campaign=newsletters&utm_source=newsletter-daily-all&utm_medium=email&utm_content=20130905

As an economist who studies health care, I find it hard to know whether to welcome or fear new technology. Surgeons can replace a heart valve with a plastic and metal one that unfolds once threaded through arteries—repairs that used to be made by cracking open the chest. Customized cancer drugs hold the promise of making fatal diseases treatable. At the same time, it’s depressingly common to hear projections of fiscal Armageddon as health-care spending drags the U.S. federal government into debt and wipes out any wage growth for the average American. Even a recent slowdown in spending growth simply postpones the inevitable date when Medicare goes bankrupt.


It may surprise you to learn that economists agree on why the fiscal outlook for health care is so dismal: the cause is the continued development and diffusion of new technologies, whether it’s new drugs for treating depression, left-ventricular assistance devices, or implantable defibrillators.
Technology doesn’t raise prices in other parts of the economy. Improvements in computers provide better products at lower prices, and automobiles are an equally good example: after adjusting for consumer price inflation, my 1988 Volkswagen Jetta would have sold new for $22,600, more than the list price of a brand-new 2013 model. And I’d take the 2013 Jetta any day; it’s a much better car (my old Jetta lacked even a lap belt).
In research with Amitabh Chandra at Harvard’s Kennedy School of Government, funded by the National Institute on Aging, I have been puzzling over why advances in medical technology lead the U.S. to spend more per person on health care than any other country in the world. We came up with two basic causes. The first is a dizzying array of different treatments, some that provide enormous health value per dollar spent and some that provide little or no value. The second is a generous system of insurance (both private and public) that pays for any treatment that doesn’t obviously harm the patient, regardless of how effective it is.
We created three “bins” of treatments, sorted according to their health benefit per dollar of spending. The category with the greatest benefit includes low-cost antibiotics for bacterial infection, a cast for a simple fracture, or aspirin and beta blockers for heart attack patients. Not all treatments in this category are inexpensive. Antiretroviral drugs for people with HIV may cost $20,000 per year, but they are still a technology home run because they keep patients alive, year after year.
A second category of technology includes procedures whose benefits are substantial for some patients, but not all. Angioplasty, in which a metal stent is used to prop open blocked blood vessels in the heart, is very cost-effective for heart attack patients treated within the first 12 hours. But many more patients get the procedure even when the value for them is less clear. Because the U.S. health-care system compensates generously for angioplasty whether it’s used correctly or not, the average value of this innovation is driven toward zero.
A third category includes treatments whose benefits are small or supported by little scientific evidence. These include expensive surgical treatments like spinal fusion for back pain, proton-beam accelerators to treat prostate cancer, or aggressive treatments for an 85-year-old patient with advanced heart failure. The prevailing evidence suggests no known medical value for any of these compared with cheaper alternatives. Yet if a hospital builds a $150 million proton accelerator, it will have every incentive to use it as frequently as possible, damn the evidence. And hospitals are loading up on such technology; the number of proton-beam accelerators in the United States is increasingly rapidly.
chart on high-cost health-care

So it’s not just “technology” that is driving our rising health-care costs; it’s the type of technology that is developed, adopted, and then diffused through hospitals and doctor’s offices. Much of the increase in observed longevity is generated by the first category of treatments. Most of the spending growth is generated by the third category, which the U.S. health-care system is uniquely, and perversely, designed to encourage. Unlike many countries, the U.S. pays for nearly any technology (and at nearly any price) without regard to economic value. For this reason, since 1980, health-care spending as a percentage of gross domestic product has grown nearly three times as rapidly in the United States as it has in other developed countries, while the nation has lagged behind in life-expectancy gains.
 Other researchers have found that just 0.5 percent of studies on new medical technologies evaluated those that work just as well as existing ones but cost less. The nearly complete isolation of both physicians and patients from the actual prices paid for treatments ensures a barren ground for these types of ideas. Why should a patient, fully covered by health insurance, worry about whether that expensive hip implant is really any better than the alternative costing half as much? And for that matter, physicians rarely if ever know the cost of what they prescribe—and are often shocked when they do find out.


The implications for innovation policy are twofold. First, we should pay only for innovations that are worth it, but without shutting out the potential for shaky new ideas that might have long-term potential. Two physicians, Steven Pearson and Peter Bach, have suggested a middle ground, where Medicare would cover such innovations for, say, three years; then, if there is still no evidence of effectiveness, Medicare would revert to paying for the standard treatment. Like many rational ideas, this one may fall victim to the internecine political struggles in Washington, D.C., where it’s controversial to suggest denying even unproven treatments for dying patients.
For this reason, the best way technology can save costs is if it is used to better organize the health-care system. While the U.S. may lead the world in developing costly new orthopedic prostheses, we’re far behind in figuring out how to get treatments to patients who want and could actually benefit from them. Doing so requires a greater emphasis on organizational change, innovations in the science of health-care delivery, and transparent prices to provide the right encouragement. This means smartphone diagnostics, technology to help physicians and nurses deliver the highest-quality care, or even drug container caps with motion detectors that let a nurse know when the patient hasn’t taken the daily dose. The overall benefits from innovation in health-care delivery could far exceed those arising from dozens of shiny new medical devices.
Jonathan S. Skinner is James Freedman Presidential Professor in the department of economics, and a professor at the Dartmouth Institute for Health Policy & Clinical Practice at the Geisel School of Medicine, Dartmouth College.